+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Curability of poor-risk metastatic sarcomatoid renal cell carcinoma with the combination of gemcitabine, 5-fluorouracil, and interferon-alfa: a case report of a 55-year-old man with a 10-year complete remission



Curability of poor-risk metastatic sarcomatoid renal cell carcinoma with the combination of gemcitabine, 5-fluorouracil, and interferon-alfa: a case report of a 55-year-old man with a 10-year complete remission



Clinical Genitourinary Cancer 11(3): 370-373




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052404419

Download citation: RISBibTeXText

PMID: 23665133

DOI: 10.1016/j.clgc.2013.04.005


Related references

Durable complete remission of metastatic sarcomatoid carcinoma of the bladder with cisplatin and gemcitabine in an 80-year-old man. Urology 58(5): 799, 2001

Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial. Lancet 375(9715): 641-648, 2010

A 51-year-old man with rapidly progressive metastatic sarcomatoid renal cell carcinoma: an apparent complete clinical response to second-line therapy with sunitinib and low-dose interferon-alpha. Clinical Advances in Hematology and Oncology 9(1): 61-64, 2011

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma. Cancer 121(19): 3435-3443, 2016

Complete remission of lung metastasis from renal cell carcinoma by a combination treatment of interferon alpha and gamma: A case report. Rinsho Hinyokika 51(8): 571-574, 1997

Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil. Journal of Clinical Oncology 18(24): 4009-4015, December 15, 2000

Treatment of metastatic renal cell carcinoma with natural interferon alpha and carmofur in combination report of a case showing a complete response. International Journal of Immunotherapy 8(1): 51-56, 1992

Combination of gemcitabine and doxorubicin in rapidly progressive metastatic renal cell carcinoma and/or sarcomatoid renal cell carcinoma. Oncology 80(3-4): 214-218, 2011

A case of metastatic renal cell carcinoma with complete remission achieved by interferon therapy. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(3 Pt 1): 566-569, 1985

Combination of gemcitabine and doxorubicin in sarcomatoid and/or rapidly progressive metastatic renal cell carcinoma (MRCC). 2007

Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma: the fine balance between toxicity and efficacy. Anti-Cancer Drugs 26(4): 469-473, 2015

Poster Combination of gemcitabine and doxorubicin in sarcomatoid and/or rapidly progressive metastatic renal cell carcinoma (Mrcc). European Journal of Cancer Suppl.s 5(4): 308-309, 2007

Complete response of lung metastasis to interferon-alpha therapy after radical nephrectomy for sarcomatoid renal cell carcinoma with Stauffer syndrome: a case report. Hinyokika Kiyo. Acta Urologica Japonica 57(5): 237-241, 2011

Interferon alfa 2b as maintenance therapy in poor risk diffuse large B-cell lymphoma in complete remission after intensive CHOP-BLEO regimens. European Journal of Haematology 66(2): 94-99, 2001

Complete remission of lung and hepatic metastases from renal cell carcinoma by interferon alpha-2b therapy: a case report. Hinyokika Kiyo. Acta Urologica Japonica 45(9): 617-619, 1999